|
1
|
Go AS, Mozaffarian D, Roger VL, Benjamin
EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al:
American Heart Association Statistics Committee and Stroke
Statistics Subcommittee: Executive summary: heart disease and
stroke statistics–2014 update: a report from the American Heart
Association. Circulation. 129:399–410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fox KA, Steg PG, Eagle KA, Goodman SG,
Anderson FA Jr, Granger CB, Flather MD, Budaj A, Quill A, Gore JM,
et al: GRACE Investigators: Decline in rates of death and heart
failure in acute coronary syndromes, 1999–2006. JAMA.
297:1892–1900. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lange RA and Hillis LD: Immediate
angioplasty for acute myocardial infarction. N Engl J Med.
328:726–728. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Simoons ML and Windecker S: Controversies
in cardiovascular medicine: Chronic stable coronary artery disease:
drugs vs. revascularization. Eur Heart J. 31:530–541. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Braunwald E and Kloner RA: Myocardial
reperfusion: A double-edged sword? J Clin Invest. 76:1713–1719.
1985. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Buja LM: Myocardial ischemia and
reperfusion injury. Cardiovasc Pathol. 14:170–175. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yellon DM and Hausenloy DJ: Myocardial
reperfusion injury. N Engl J Med. 357:1121–1135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moens AL, Claeys MJ, Timmermans JP and
Vrints CJ: Myocardial ischemia/reperfusion-injury, a clinical view
on a complex pathophysiological process. Int J Cardiol.
100:179–190. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mozaffari MS, Liu JY, Abebe W and Baban B:
Mechanisms of load dependency of myocardial ischemia reperfusion
injury. Am J Cardiovasc Dis. 3:180–196. 2013.PubMed/NCBI
|
|
10
|
Eefting F, Rensing B, Wigman J, Pannekoek
WJ, Liu WM, Cramer MJ, Lips DJ and Doevendans PA: Role of apoptosis
in reperfusion injury. Cardiovasc Res. 61:414–426. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
MacLellan WR and Schneider MD: Death by
design. Programmed cell death in cardiovascular biology and
disease. Circ Res. 81:137–144. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abbate A, Bussani R, Amin MS, Vetrovec GW
and Baldi A: Acute myocardial infarction and heart failure: Role of
apoptosis. Int J Biochem Cell Biol. 38:1834–1840. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fliss H and Gattinger D: Apoptosis in
ischemic and reperfused rat myocardium. Circ Res. 79:949–956. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gill C, Mestril R and Samali A: Losing
heart: The role of apoptosis in heart disease–a novel therapeutic
target? FASEB J. 16:135–146. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang HF, Yi YH, Wang ZZ, Hu WJ and Li YQ:
Studies on the triterpenoid saponins of the root bark of Aralia
taibaiensis. Yao Xue Xue Bao. 31:517–523. 1996.In Chinese.
|
|
16
|
Xi M, Hai C, Tang H, Wen A, Chen H, Liu R,
Liang X and Chen M: Antioxidant and antiglycation properties of
triterpenoid saponins from Aralia taibaiensis traditionally used
for treating diabetes mellitus. Redox Rep. 15:20–28. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang HF, Yi YH, Wang ZZ, Jiang YP and Li
YQ: Oleanolic acid saponins from the root bark of Aralia
taibaiensis. Yao Xue Xue Bao. 32:685–690. 1997.In Chinese.
|
|
18
|
Li YN, Guo Y, Xi MM, Yang P, Zhou XY, Yin
S, Hai CX, Li JG and Qin XJ: Saponins from Aralia taibaiensis
attenuate D-galactose-induced aging in rats by activating FOXO3a
and Nrf2 pathways. Oxid Med Cell Longev. 2014:3205132014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weng Y, Yu L, Cui J, Zhu YR, Guo C, Wei G,
Duan JL, Yin Y, Guan Y, Wang YH, et al: Antihyperglycemic,
hypolipidemic and antioxidant activities of total saponins
extracted from Aralia taibaiensis in experimental type 2 diabetic
rats. J Ethnopharmacol. 152:553–560. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li C, Liu Z, Tian J, Li G, Jiang W, Zhang
G, Chen F, Lin P and Ye Z: Protective roles of Asperosaponin VI, a
triterpene saponin isolated from Dipsacus asper Wall on acute
myocardial infarction in rats. Eur J Pharmacol. 627:235–241. 2010.
View Article : Google Scholar
|
|
21
|
Zhang JY, Chen ZW and Yao H: Protective
effect of urantide against ischemia-reperfusion injury via protein
kinase C and phosphtidylinositol 3′-kinase - Akt pathway. Can J
Physiol Pharmacol. 90:637–645. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Koyama T, Temma K and Akera T:
Reperfusion-induced contracture develops with a decreasing [Ca2+]i
in single heart cells. Am J Physiol. 261:H1115–H1122.
1991.PubMed/NCBI
|
|
23
|
Haunstetter A and Izumo S: Apoptosis:
Basic mechanisms and implications for cardiovascular disease. Circ
Res. 82:1111–1129. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yue TL, Wang C, Gu JL, Ma XL, Kumar S, Lee
JC, Feuerstein GZ, Thomas H, Maleeff B and Ohlstein EH: Inhibition
of extracellular signal-regulated kinase enhances
Ischemia/Reoxygenation-induced apoptosis in cultured cardiac
myocytes and exaggerates reperfusion injury in isolated perfused
heart. Circ Res. 86:692–699. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hausenloy DJ and Yellon DM:
Preconditioning and postconditioning: united at reperfusion.
Pharmacol Ther. 116:173–191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maxwell SR and Lip GY: Reperfusion injury:
a review of the pathophysiology, clinical manifestations and
therapeutic options. Int J Cardiol. 58:95–117. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Lu S, Wang H and Zheng Q:
Protective role of Aralia elata polysaccharide on
mercury(II)-induced cardiovascular oxidative injury in rats. Int J
Biol Macromol. 59:301–304. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang J, Wang H and Zheng Q:
Cardioprotective effect of Aralia elata polysaccharide on
myocardial ischemic reperfusion (IR) injury in rats. Int J Biol
Macromol. 59:328–332. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang J, Wang H, Xue Y and Zheng Q:
Cardioprotective and antioxidant activities of a polysaccharide
from the root bark of Aralia elata (Miq.) Seem. Carbohydr Polym.
93:442–448. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang M, Xu X, Xu H, Wen F, Zhang X, Sun H,
Yao F, Sun G and Sun X: Effect of the total saponins of Aralia
elata (Miq) Seem on cardiac contractile function and intracellular
calcium cycling regulation. J Ethnopharmacol. 155:240–247. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mohanty IR, Maheshwari U, Joseph D and
Deshmukh Y: Bacopa monniera protects rat heart against
ischaemia-reperfusion injury: Role of key apoptotic regulatory
proteins and enzymes. J Pharm Pharmacol. 62:1175–1184. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ertracht O, Malka A, Atar S and Binah O:
The mitochondria as a target for cardioprotection in acute
myocardial ischemia. Pharmacol Ther. 142:33–40. 2014. View Article : Google Scholar
|
|
33
|
Crow MT, Mani K, Nam YJ and Kitsis RN: The
mitochondrial death pathway and cardiac myocyte apoptosis. Circ
Res. 95:957–970. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xie Z, Koyama T, Suzuki J, Fujii Y,
Togashi H, Sawa H and Nagashima K: Coronary reperfusion following
ischemia: Different expression of bcl-2 and bax proteins, and
cardiomyocyte apoptosis. Jpn Heart J. 42:759–770. 2001. View Article : Google Scholar
|
|
35
|
Armstrong JS: Mitochondria: A target for
cancer therapy. Br J Pharmacol. 147:239–248. 2006. View Article : Google Scholar
|
|
36
|
Dorn GW II: Apoptotic and non-apoptotic
programmed cardiomyocyte death in ventricular remodelling.
Cardiovasc Res. 81:465–473. 2009. View Article : Google Scholar :
|
|
37
|
Steinberg GR and Kemp BE: AMPK in Health
and Disease. Physiol Rev. 89:1025–1078. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang P, Hu X, Xu X, Fassett J, Zhu G,
Viollet B, Xu W, Wiczer B, Bernlohr DA, Bache RJ, et al: AMP
activated protein kinase-alpha2 deficiency exacerbates
pressure-overload-induced left ventricular hypertrophy and
dysfunction in mice. Hypertension. 52:918–924. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Horman S, Beauloye C, Vanoverschelde JL
and Bertrand L: AMP-activated protein kinase in the control of
cardiac metabolism and remodeling. Curr Heart Fail Rep. 9:164–173.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lopaschuk GD: AMP-activated protein kinase
control of energy metabolism in the ischemic heart. Int J Obes.
32(Suppl 4): S29–S35. 2008. View Article : Google Scholar
|
|
41
|
Russell RR III, Li J, Coven DL, Pypaert M,
Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ and Young LH:
AMP-activated protein kinase mediates ischemic glucose uptake and
prevents postischemic cardiac dysfunction, apoptosis, and injury. J
Clin Invest. 114:495–503. 2004. View Article : Google Scholar : PubMed/NCBI
|
